BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Citi
McKinsey
Medtronic
Farmers Insurance
Fuji
Colorcon
Merck
Argus Health
Cipla

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020479

« Back to Dashboard

NDA 020479 describes GASTROCROM, which is a drug marketed by Ucb Inc and Mylan Speciality Lp and is included in two NDAs. It is available from four suppliers. Additional details are available on the GASTROCROM profile page.

The generic ingredient in GASTROCROM is cromolyn sodium. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
Summary for 020479
Tradename:GASTROCROM
Applicant:Mylan Speciality Lp
Ingredient:cromolyn sodium
Patents:0
Therapeutic Class:Ophthalmic Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020479
Physiological EffectDecreased Histamine Release
Medical Subject Heading (MeSH) Categories for 020479
Suppliers and Packaging for NDA: 020479
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GASTROCROM cromolyn sodium CONCENTRATE;ORAL 020479 NDA MEDA Pharmaceuticals 0037-0678 0037-0678-96 12 POUCH in 1 CARTON (0037-0678-96) > 8 AMPULE in 1 POUCH (0037-0678-08) > 5 mL in 1 AMPULE
GASTROCROM cromolyn sodium CONCENTRATE;ORAL 020479 NDA Jazz Pharmaceuticals Commercial Corp. 18860-678 18860-678-70 12 POUCH in 1 CARTON (18860-678-70) > 8 AMPULE in 1 POUCH > 5 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CONCENTRATE;ORALStrength100MG/5ML
Approval Date:Feb 29, 1996TE:AARLD:Yes

Expired US Patents for NDA 020479

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp GASTROCROM cromolyn sodium CONCENTRATE;ORAL 020479-001 Feb 29, 1996 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp GASTROCROM cromolyn sodium CONCENTRATE;ORAL 020479-001 Feb 29, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Mallinckrodt
Express Scripts
Novartis
Deloitte
Medtronic
Cipla
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot